| Literature DB >> 26702396 |
Alison C Simioni1, Alain Dagher1, Lesley K Fellows1.
Abstract
Dopamine depletion in the putamen is associated with altered motor network functional connectivity in people with Parkinson's disease (PD), but the functional significance of these changes remains unclear, attributed to either pathological or compensatory mechanisms in different studies. Here, we examined the effects of PD on dorsal caudal putamen functional connectivity, off and on dopamine replacement therapy (DRT), using resting state fMRI. Motor performance was assessed with the Purdue pegboard task. Twenty-one patients with mild-moderate Parkinson's disease were studied twice, once after an overnight DRT washout and once after the administration of a standard dose of levodopa (Sinemet), and compared to 20 demographically-matched healthy control participants. PD patients off DRT showed increased putamen functional connectivity with both the cerebellum (lobule V) and primary motor cortex (M1), relative to healthy controls. Greater putamen-cerebellar functional connectivity was significantly correlated with better motor performance, whereas greater putamen-M1 functional connectivity was predictive of poorer motor performance. The administration of levodopa improved motor performance in the PD group, as expected, and reduced putamen-cerebellar connectivity to levels comparable to the healthy control group. The strength of putamen-cerebellar functional connectivity continued to predict motor performance in the PD group while on levodopa. These findings argue that increased putamen-M1 functional connectivity reflects a pathological change, deleterious to motor performance. In contrast, increased putamen-cerebellar connectivity reflects a compensatory mechanism.Entities:
Keywords: Basal ganglia; Cerebellum; Dopamine; Motor cortex; Putamen
Mesh:
Substances:
Year: 2015 PMID: 26702396 PMCID: PMC4669533 DOI: 10.1016/j.nicl.2015.11.005
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Characteristics of subjects (mean (S.D.)).
| PD | HCTL | |
|---|---|---|
| N | 21 | 20 |
| H & Y | 2.4 (0.6) | n/a |
| Education (years) | 16.1 (3.7) | 15.8 (2.9) |
| Disease duration (years) | 6.6 (3.3) | n/a |
| UPDRS | ||
| Off DRT | 15.3 (5.2) | n/a |
| On DRT | 11.0 (4.4) | n/a |
| LEDD (mg) | 592 (382) | n/a |
| DA LEDD (mg) | 170 (102) | n/a |
| BDI | 6.9 (3.7) | 2.7 (4.5) |
| MoCA | 26.2 (2.1) | 27.6 (1.3) |
| IQ | 118 (8) | 116 (4) |
BDI, Beck Depression Inventory; DA, dopamine agonist; DRT, dopamine replacement therapy; H & Y, Hoehn & Yahr rating; LEDD, levodopa equivalent daily dose; MoCA, Montreal Cognitive Assessment; IQ estimated with the Wechsler Abbreviated Scale of Intelligence (WASI–II); and UPDRS, Unified Parkinson's Disease Rating Scale.
p < 0.001, PD off DRT–on DRT.
p < 0.05, PD-HCTL.
Fig. 1Patterns of dorsal caudal putamen functional connectivity in PD patients off and on DRT and healthy control subjects over two runs, approximately 1 h apart. Maps are thresholded at a z-score > 2.3, cluster significance: p < 0.05, corrected for multiple comparisons. Images are displayed according to radiological convention (left is right). L, left; and R, right.
Fig. 2Greater putamen functional connectivity in PD patients off DRT relative to healthy control subjects (min z > 2.3; cluster significance p < 0.05). L, left; and R, right.
Fig. 3Regions showing significantly greater functional connectivity with putamen in PD patients off compared to on DRT (min z > 2.3; cluster significance p < 0.05). L, left; and R, right. A, anterior; and P, posterior.
Fig. 4Scatter plots with best-fitting regression lines for the Purdue pegboard score as a function of (a) putamen–cerebellar functional connectivity and, (b) putamen–motor cortex functional connectivity. Data for PD off (empty circles; dashed line) and PD on (filled circles; solid line) are from the same cohort of subjects tested after overnight DRT washout (‘off’), and 45 min after a standard dose of Sinemet (‘on’).